# EDGAR Filing Document

**Accession Number:** 0001946399
**File Stem:** 0001104659-23-005236
**Filing Date:** 2023-1
**Character Count:** 4657
**Document Hash:** 0148c240535f2f454b6b4ca94c497652
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-005236.hdr.sgml**: 20230120

**ACCESSION NUMBER**: 0001104659-23-005236

**CONFORMED SUBMISSION TYPE**: 8-A12B

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230120

**DATE AS OF CHANGE**: 20230120

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** YishengBio Co., Ltd
- **CENTRAL INDEX KEY:** 0001946399
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-A12B
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41598
- **FILM NUMBER:** 23538999

**BUSINESS ADDRESS:**
- **STREET 1:** BUILDING NO. 2, 38 YONGDA ROAD
- **STREET 2:** DAXING BIOMEDICAL INDUSTRY PARK
- **CITY:** DAXING DISTRICT, BEIJING
- **STATE:** F4
- **ZIP:** 102629
- **BUSINESS PHONE:** 861089202086

**MAIL ADDRESS:**
- **STREET 1:** BUILDING NO. 2, 38 YONGDA ROAD
- **STREET 2:** DAXING BIOMEDICAL INDUSTRY PARK
- **CITY:** DAXING DISTRICT, BEIJING
- **STATE:** F4
- **ZIP:** 102629

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-A**

**FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES**

**PURSUANT TO SECTION 12(b) OR (g) OF**

**THE SECURITIES EXCHANGE ACT OF 1934**

**YISHENGBIO CO., LTD**

**(Exact name of Registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Cayman Islands** | **Not Applicable** |
| **(State or other jurisdiction of incorporation or organization)** | **(I.R.S. Employer Identification No.)** |

---

**Building No. 2, 38 Yongda Road<br> Daxing Biomedical Industry Park<br> Daxing District, Beijing, PRC<br> Tel: 010-89202086** **<br> (Address of principal executive offices including zip code)**

**Securities to be registered pursuant to Section 12(b) of the Act:**

---

| | |
|:---|:---|
| **Title of each class** | **Name of each exchange on which** |
| **to be so registered** | **each class is to be registered** |
| **Ordinary Shares, $0.00002 par value per share** | **The Nasdaq Stock Market LLC** |
| **Warrants, each exercisable for one Ordinary Share** | **The Nasdaq Stock Market LLC** |

---

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ⌧

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ◻

**Securities Act registration statement file number to which this form relates:**

**333-269031**

**Securities to be registered pursuant to Section 12(g) of the Act:**

**None**

**Item 1. Description of Registrant's Securities to be Registered**

The securities to be registered hereby are the ordinary shares (the "YS Biopharma Ordinary Shares"), par value US$0.00002 per share, of YishengBio Co., Ltd (the "Registrant") and warrants to purchase YS Biopharma Ordinary Shares (the "YS Biopharma Warrants"), assuming the completion of the business combination. For a description of YS Biopharma Ordinary Shares and YS Biopharma Warrants, reference is made to the information set forth under the headings "Description of YS Biopharma's Securities" contained in the Registrant's Registration Statement on Form F-4 (File No. 333-269031), as initially filed with the U.S. Securities and Exchange Commission (the "Commission") on December 28, 2022, as amended (the "Registration Statement"). In addition, all of the above-referenced descriptions included in any prospectus forming a part of the Registration Statement subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, shall be deemed to be incorporated by reference herein.

**Item 2. Exhibits**

Under the "Instructions as to Exhibits" section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

**SIGNATURE**

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: January 20, 2023 | **YISHENGBIO CO., LTD** | **YISHENGBIO CO., LTD** |
|  | By: | /s/ Yi Zhang |
|  |  | Name: Yi Zhang |
|  |  | Title: Chairman and Director |

---